Efficacy and safety of sacubitril-valsartan in lowering blood pressure in non-dialysis-dependent patients with stage 3-5 chronic kidney disease

导出

摘要 Objective To evaluate the efficacy and safety of sacubitril-valsartan (SV) in reducing blood pressure in patients with non-dialysis-dependent chronic kidney disease(NDD-CKD) stage 3-5 and concomitant hypertension.

作者 YAN Yu 闫宇(Dept Nephrol,Zhongda Hosp,Southeast Univ,Nanjing 210009,China)

机构地区 Dept Nephrol

出处《China Medical Abstracts(Internal Medicine)》 2024年第3期182-183,共2页 中国医学文摘（内科学分册英文版）

关键词 DIALYSIS PATIENTS KIDNEY

分类号 R69 [医药卫生—泌尿科学]

引文网络
相关文献

1闫宇,刘玉秋,李晓敏,郑婧,曹婧媛,尹清,张晓良,刘必成,王彬.沙库巴曲-缬沙坦在非透析依赖性慢性肾脏病3~5期合并高血压患者中降压的有效性和安全性[J].中华肾脏病杂志,2024,40(4):255-260. 被引量：1
2Dong-Hua Liu,Xiao-Ming Dong,Wen-Jie Long.Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus[J].World Journal of Clinical Cases,2024,12(36):6935-6938.
3Jie XIN,Huai ZHANG,Yaolin SHI,Felipe ORELLANA-ROVIROSA.Effects of upper mantle wind on mantle plume morphology and hotspot track:Numerical modeling[J].Science China Earth Sciences,2024,67(12):3881-3899.

China Medical Abstracts(Internal Medicine)

2024年第3期

浏览历史

内容加载中请稍等...

Efficacy and safety of sacubitril-valsartan in lowering blood pressure in non-dialysis-dependent patients with stage 3-5 chronic kidney disease

相关作者

相关机构

相关主题

浏览历史